Susquehanna Maintains Negative on RXO, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Susquehanna analyst Bascome Majors maintains a Negative rating on RXO (NYSE:RXO) and lowers the price target from $18 to $15.
February 09, 2024 | 3:13 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Susquehanna maintains a Negative rating on RXO and lowers the price target from $18 to $15.
The reduction in price target by Susquehanna, accompanied by a maintained Negative rating, suggests a bearish outlook on RXO's stock in the short term. This could lead to decreased investor confidence and potentially lower stock prices.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100